Aptorum Group Limited - APM Company Long-Term Liabilities

Official company branding of Aptorum Group Ltd (APM)

The development of new compounds at Aptorum Group Limited (APM) relies on collaboration with Hong Kong universities, although strict FDA oversight is slowing product launches. Stable raw material supply chains and secure delivery to clinics ensure uninterrupted research, with the indicator standing at 0.00. Securities price action on GURU.Markets reflects the impact of patents and breakthroughs in treating metabolic disorders.

APM Aptorum Group Limited Company Long-Term Liabilities (07/04/2022 - 07/20/2026)

Metric breakdowns and analytics for Aptorum Group (APM)

- price and consensus price forecast:
Price Performance Chart Aptorum Group Ltd|APM - Price Target Chart
- market capitalization data:
Market Valuation Aptorum Group|APM - Enterprise Value
- book capitalization data:
Book Value per Share Aptorum Group|APM - Company Net Assets|Market Value to Book Value aptorumgroup.com|APM - Aggregate Company Assets
- debt and liquidity data:
Debt to Capital Aptorum Group Limited|APM - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Aptorum Group Ltd|APM - Company Aggregate Debts|Debt to Net Assets Ratio Aptorum Group|APM - Company Long-Term Debts|Short-Term Debt Aptorum Group
Comprehensive company analysis:APM (Aptorum Group Limited)
Mass-produced product of aptorumgroup.com

For the long-term investor, the reliability of Aptorum Group Limited is determined by its ability to fund costly clinical developments without a critical increase in debt load. This indicator aggregates all obligations with a maturity of more than one year; therefore, analyzing the size of the firm's long-term borrowings allows for an assessment of credit risk and the financial stability of the business during the period of bringing new drugs to market.

Direct competitors

haleon.com - Company Long-Term Loans and Borrowings|KVUE: Company Long-Term Debt|VRNA - Company Long-Term Liabilities|MENS: Company Long-Term Debts|Company Long-Term Debts Ligand Corp|AMRX - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings PRGO|Alvotech SA - Company Long-Term Debt|Long-Term Debt Liquidia Corp LQDA|Company Long-Term Liabilities Galapagos Genomics (GLPG)|Amount of Long-Term Liabilities ANI Pharmaceuticals Corp ANIP|Company Long-Term Debts MannKind Corporation (MNKD)|AMPH - Company Long-Term Loans and Borrowings|Company Long-Term Debts PCRX|SPRY (ARS Pharmaceuticals Inc) - Long-Term Debt|TBPH - Company Long-Term Debt|Company Long-Term Loans and Borrowings Aquestive Corp|Company Long-Term Debts SCPH|Company Long-Term Debts TECX (tectonictx.com)|Tonix Pharmaceuticals Holding Corp. (TNXP) - Company Long-Term Debt|SXTC - Long-Term Liabilities|Company Long-Term Liabilities Eupraxia Pharma EPRX|BHST: Amount of Long-Term Liabilities|Company Long-Term Debt EXOZ|ORMP (Oramed Pharmaceuticals Inc.) - Long-Term Debt|ENTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings MindWalk Holdings, Inc. (HYFT)|Company Long-Term Liabilities ABVC|Company Long-Term Debts CPIX (Cumberland Corp)|Quantum BioPharma Ltd - Company Long-Term Debt|FGEN - Company Long-Term Liabilities|Company Long-Term Liabilities Telomir Pharmaceuticals, Inc. (TELO)|RANI - Company Long-Term Loans and Borrowings|Company Long-Term Debts SNYR (synergychc.com)|RLYB (Rallybio) - Long-Term Indebtedness|LEXX - Company Long-Term Debt|Company Long-Term Loans and Borrowings PULM|Pheton Holdings Ltd - Company Long-Term Debt|Long-Term Debt Lyra Therapeutics Inc. LYRA|Company Long-Term Liabilities IBO (Impact BioMedical Inc)|TNF Pharmaceuticals Inc. - Company Long-Term Debts|Company Long-Term Debt cbdMD Corp|painreform.com (PRFX) - Long-Term Liabilities|Company Long-Term Liabilities altamiratherapeutics.com CYTO|LIPO (Lipella Pharmaceuticals Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Optinose|Company Long-Term Debt Pieris Pharma|PROC (Procaps Group S.A.) - Company Long-Term Debts|Long-Term Debt Volume PTPI (petrospharma.com)|Qilian International Holding - Company Long-Term Debt|Company Long-Term Liabilities Acelyrin Inc. SLRN|Company Long-Term Debts TFFP (TFF Pharma)